Skip to content

Regulation of IL6 / STAT pathway based on microrna-451a Discussion on the prethrombotic state of repeated implant failure treated by Acupuncture Mechanism of action

Regulation of IL6 / STAT pathway based on microrna-451a Discussion on the prethrombotic state of repeated implant failure treated by Acupuncture Mechanism of action

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039089
Enrollment
Unknown
Registered
2020-10-16
Start date
2020-10-14
Completion date
Unknown
Last updated
2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Repeated implantation failure

Interventions

Sponsors

Fujian Maternity and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of Western medicine and traditional Chinese medicine; 2. Patients who have obtained excellent embryos of grade 1-2 after oocyte retrieval; 3. Patients aged 20-40 years; 4. Patients have independent ability, agree to accept the treatment plan of this study, obey the research arrangement, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients under 20 years old or over 40 years old; 2. Patients with organic diseases or other endocrine diseases were excluded: female genital malformations, including uterine malformations (single horn uterus, double horn uterus, mediastinal uterus and double uterus), adenomyosis, submucosal myoma and intrauterine adhesions, hyperprolactinemia, abnormal thyroid function and other reproductive endocrine diseases and autoimmune diseases; 3. Patients with primary diseases such as liver and kidney, cerebrovascular, cardiovascular and hematopoietic disorders, and psychosis; 4. Patients allergic to aspirin or other salicylates or other components of drugs; 5. Patients with history of gastric or duodenal ulcer or gastrointestinal bleeding or other cases of aspirin forbidden; 6. Data were incomplete.

Design outcomes

Primary

MeasureTime frame
TCM symptom score;pregnancy outcome;Coagulation related indicators;JAK, stat and other gene transcription levels;Expression and phosphorylation of JAK and stat related proteins;

Secondary

MeasureTime frame
Safety inspection index;

Countries

China

Contacts

Public ContactYou Xiumi

Fujian Maternity and Child Health Hospital

657932550@qq.com+86 18060840071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026